vs

Side-by-side financial comparison of Claritev Corp (CTEV) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.

Claritev Corp is the larger business by last-quarter revenue ($246.6M vs $220.8M, roughly 1.1× UNIVERSAL TECHNICAL INSTITUTE INC). UNIVERSAL TECHNICAL INSTITUTE INC runs the higher net margin — 5.8% vs -32.7%, a 38.5% gap on every dollar of revenue. On growth, UNIVERSAL TECHNICAL INSTITUTE INC posted the faster year-over-year revenue change (9.6% vs 6.2%). Claritev Corp produced more free cash flow last quarter ($36.4M vs $-19.2M). Over the past eight quarters, UNIVERSAL TECHNICAL INSTITUTE INC's revenue compounded faster (9.5% CAGR vs 2.5%).

Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.

CTEV vs UTI — Head-to-Head

Bigger by revenue
CTEV
CTEV
1.1× larger
CTEV
$246.6M
$220.8M
UTI
Growing faster (revenue YoY)
UTI
UTI
+3.4% gap
UTI
9.6%
6.2%
CTEV
Higher net margin
UTI
UTI
38.5% more per $
UTI
5.8%
-32.7%
CTEV
More free cash flow
CTEV
CTEV
$55.5M more FCF
CTEV
$36.4M
$-19.2M
UTI
Faster 2-yr revenue CAGR
UTI
UTI
Annualised
UTI
9.5%
2.5%
CTEV

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CTEV
CTEV
UTI
UTI
Revenue
$246.6M
$220.8M
Net Profit
$-80.6M
$12.8M
Gross Margin
Operating Margin
-3.1%
7.1%
Net Margin
-32.7%
5.8%
Revenue YoY
6.2%
9.6%
Net Profit YoY
41.6%
-42.1%
EPS (diluted)
$-4.88
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTEV
CTEV
UTI
UTI
Q4 25
$246.6M
$220.8M
Q3 25
$246.0M
$222.4M
Q2 25
$241.6M
$204.3M
Q1 25
$231.3M
$207.4M
Q4 24
$232.1M
$201.4M
Q3 24
$230.5M
$196.4M
Q2 24
$233.5M
$177.5M
Q1 24
$234.5M
$184.2M
Net Profit
CTEV
CTEV
UTI
UTI
Q4 25
$-80.6M
$12.8M
Q3 25
$-69.8M
$18.8M
Q2 25
$-62.6M
$10.7M
Q1 25
$-71.3M
$11.4M
Q4 24
$-138.0M
$22.2M
Q3 24
$-391.4M
$18.8M
Q2 24
$-576.7M
$5.0M
Q1 24
$-539.7M
$7.8M
Operating Margin
CTEV
CTEV
UTI
UTI
Q4 25
-3.1%
7.1%
Q3 25
4.1%
11.2%
Q2 25
6.9%
6.9%
Q1 25
4.2%
8.1%
Q4 24
-17.8%
13.6%
Q3 24
-146.7%
13.3%
Q2 24
-224.4%
4.2%
Q1 24
-207.4%
6.1%
Net Margin
CTEV
CTEV
UTI
UTI
Q4 25
-32.7%
5.8%
Q3 25
-28.4%
8.4%
Q2 25
-25.9%
5.2%
Q1 25
-30.8%
5.5%
Q4 24
-59.4%
11.0%
Q3 24
-169.8%
9.6%
Q2 24
-247.0%
2.8%
Q1 24
-230.1%
4.2%
EPS (diluted)
CTEV
CTEV
UTI
UTI
Q4 25
$-4.88
$0.23
Q3 25
$-4.23
$0.33
Q2 25
$-3.81
$0.19
Q1 25
$-4.38
$0.21
Q4 24
$-8.49
$0.40
Q3 24
$-24.25
$0.35
Q2 24
$-35.78
$0.09
Q1 24
$-33.40
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTEV
CTEV
UTI
UTI
Cash + ST InvestmentsLiquidity on hand
$16.8M
$162.8M
Total DebtLower is stronger
$4.6B
$101.4M
Stockholders' EquityBook value
$-173.9M
$335.9M
Total Assets
$4.9B
$834.0M
Debt / EquityLower = less leverage
0.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTEV
CTEV
UTI
UTI
Q4 25
$16.8M
$162.8M
Q3 25
$39.2M
$169.1M
Q2 25
$56.4M
$70.7M
Q1 25
$23.1M
$96.0M
Q4 24
$16.8M
$172.0M
Q3 24
$86.6M
$161.9M
Q2 24
$48.8M
$115.5M
Q1 24
$58.7M
$116.1M
Total Debt
CTEV
CTEV
UTI
UTI
Q4 25
$4.6B
$101.4M
Q3 25
$4.5B
$87.1M
Q2 25
$4.5B
$73.8M
Q1 25
$4.5B
$94.4M
Q4 24
$4.5B
$120.1M
Q3 24
$4.5B
$125.7M
Q2 24
$4.5B
$137.3M
Q1 24
$4.5B
$141.9M
Stockholders' Equity
CTEV
CTEV
UTI
UTI
Q4 25
$-173.9M
$335.9M
Q3 25
$-101.8M
$328.1M
Q2 25
$-39.9M
$306.8M
Q1 25
$14.8M
$293.9M
Q4 24
$84.0M
$280.0M
Q3 24
$207.6M
$260.2M
Q2 24
$603.4M
$239.4M
Q1 24
$1.2B
$232.6M
Total Assets
CTEV
CTEV
UTI
UTI
Q4 25
$4.9B
$834.0M
Q3 25
$5.0B
$826.1M
Q2 25
$5.1B
$740.8M
Q1 25
$5.1B
$720.4M
Q4 24
$5.2B
$753.8M
Q3 24
$5.3B
$744.6M
Q2 24
$5.7B
$706.0M
Q1 24
$6.4B
$702.1M
Debt / Equity
CTEV
CTEV
UTI
UTI
Q4 25
0.30×
Q3 25
0.27×
Q2 25
0.24×
Q1 25
304.87×
0.32×
Q4 24
53.67×
0.43×
Q3 24
21.73×
0.48×
Q2 24
7.48×
0.57×
Q1 24
3.85×
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTEV
CTEV
UTI
UTI
Operating Cash FlowLast quarter
$66.3M
$3.1M
Free Cash FlowOCF − Capex
$36.4M
$-19.2M
FCF MarginFCF / Revenue
14.8%
-8.7%
Capex IntensityCapex / Revenue
12.1%
10.1%
Cash ConversionOCF / Net Profit
0.24×
TTM Free Cash FlowTrailing 4 quarters
$-12.3M
$16.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTEV
CTEV
UTI
UTI
Q4 25
$66.3M
$3.1M
Q3 25
$19.9M
$57.1M
Q2 25
$61.2M
$18.1M
Q1 25
$-30.1M
$-789.0K
Q4 24
$-33.4M
$23.0M
Q3 24
$72.8M
$67.5M
Q2 24
$18.5M
$10.0M
Q1 24
$49.7M
$-2.5M
Free Cash Flow
CTEV
CTEV
UTI
UTI
Q4 25
$36.4M
$-19.2M
Q3 25
$-16.3M
$40.6M
Q2 25
$36.6M
$6.8M
Q1 25
$-68.9M
$-11.7M
Q4 24
$-63.8M
$19.6M
Q3 24
$41.1M
$60.0M
Q2 24
$-7.0M
$3.0M
Q1 24
$19.2M
$-8.4M
FCF Margin
CTEV
CTEV
UTI
UTI
Q4 25
14.8%
-8.7%
Q3 25
-6.6%
18.3%
Q2 25
15.2%
3.4%
Q1 25
-29.8%
-5.7%
Q4 24
-27.5%
9.7%
Q3 24
17.8%
30.6%
Q2 24
-3.0%
1.7%
Q1 24
8.2%
-4.6%
Capex Intensity
CTEV
CTEV
UTI
UTI
Q4 25
12.1%
10.1%
Q3 25
14.7%
7.4%
Q2 25
10.2%
5.5%
Q1 25
16.8%
5.3%
Q4 24
13.1%
1.7%
Q3 24
13.8%
3.8%
Q2 24
10.9%
4.0%
Q1 24
13.0%
3.2%
Cash Conversion
CTEV
CTEV
UTI
UTI
Q4 25
0.24×
Q3 25
3.04×
Q2 25
1.69×
Q1 25
-0.07×
Q4 24
1.04×
Q3 24
3.58×
Q2 24
2.01×
Q1 24
-0.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTEV
CTEV

Segment breakdown not available.

UTI
UTI

UTI$142.8M65%
Concorde$78.0M35%

Related Comparisons